BlackRock Fund Advisors - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2016$15,602,000
-27.2%
7,359,385
+15.0%
0.00%
-25.0%
Q3 2016$21,445,000
+13.9%
6,401,415
+6.7%
0.00%0.0%
Q2 2016$18,830,000
-4.3%
5,996,693
+1.5%
0.00%
-20.0%
Q1 2016$19,682,000
-55.3%
5,910,486
-52.5%
0.01%
-50.0%
Q4 2015$44,026,000
-31.1%
12,436,795
-2.0%
0.01%
-41.2%
Q3 2015$63,861,000
-23.4%
12,696,043
-2.1%
0.02%
-15.0%
Q2 2015$83,369,000
-11.3%
12,965,652
-3.0%
0.02%
-9.1%
Q1 2015$94,015,000
-0.9%
13,363,921
+8.6%
0.02%
-4.3%
Q4 2014$94,863,000
+10.0%
12,303,913
+6.6%
0.02%
-4.2%
Q3 2014$86,231,000
-21.7%
11,543,595
+1.4%
0.02%
-22.6%
Q2 2014$110,199,000
+15.2%
11,384,180
-1.1%
0.03%
+10.7%
Q1 2014$95,661,000
+4.7%
11,511,495
+6.3%
0.03%0.0%
Q4 2013$91,365,000
+7.9%
10,825,279
+1.8%
0.03%
-3.4%
Q3 2013$84,711,000
+10.8%
10,628,790
+7.3%
0.03%
+3.6%
Q2 2013$76,473,0009,905,8480.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders